Salvianolic Acid C Activates the AMPK Pathway to Inhibit Ferroptosis and Alleviate Cardiomyocyte Injury after Acute Myocardial Infarction
By: Yanping Zeng, Lin Chen, Zhenhua Qian, Weixing Ma, Cheng Ma, Yan Wang and Guanfeng Zhu
References
- Cadenas S (2018) ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection. Free Radic Biol Med 117:76–89.
https://doi.org/10.1016/j.freeradbiomed.2018.01.024 - Carling D (2017) AMPK signalling in health and disease. Curr Opin Cell Biol 45:31–37.
https://doi.org/10.1016/j.ceb.2017.01.005 - Chai R, Ye Z, Xue W et al. (2023) Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction. Front Cell Dev Biol 11:1252942.
https://doi.org/10.3389/fcell.2023.1252942 - Chien LH, Wu CT, Deng JS et al. (2021) Salvianolic acid C Protects against cisplatin-induced acute kidney injury through attenuation of inflammation, oxidative stress and apoptotic effects and activation of the CaMKK-AMPK-Sirt1-associated signaling pathway in mouse models. Antioxidants 10:1620.
https://doi.org/10.3390/antiox10101620 - Cui J, Pu Q (2024) Study on the therapeutic value of shexiang tongxin dropping pills in patients with stable angina pectoris of coronary heart disease complicated with cognitive impairment. Actas Esp Psiquiatr 52:37–44.
https://actaspsiquiatria.es/index.php/actas/article/view/1547 - Duan Y, An W, Wu H et al. (2019) Salvianolic acid C attenuates LPS-induced inflammation and apoptosis in human periodontal ligament stem cells via toll-like receptors 4 (TLR4)/nuclear factor kappa B (NF-κB) pathway. Med Sci Monit 25:9499–9508.
https://doi.org/10.12659/MSM.918940 - Endale HT, Tesfaye W, Mengstie TA (2023) ROS induced lipid peroxidation and their role in ferroptosis. Front Cell Dev Biol 11:1226044.
https://doi.org/10.3389/fcell.2023.1226044 - Fang W, Xie S, Deng W (2024) Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future. Cell Biol Toxicol 40:17.
https://doi.org/10.1007/s10565-024-09853-w - Galli M, Niccoli G, De Maria G et al. (2024) Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction. Nat Rev Cardiol 21:283–298.
https://doi.org/10.1038/s41569-023-00953-4 - Guo W, Xu X, Xiao Y et al. (2024) Salvianolic acid C attenuates cerebral ischemic injury through inhibiting neuroinflammation via the TLR4-TREM1-NF-κB pathway. Chin Med 19:46.
https://doi.org/10.1186/s13020-024-00914-0 - Herzig S, Shaw RJ (2018) AMPK: Guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol 19:121–135.
https://doi.org/10.1038/nrm.2017.95 - Lai XX, Zhang N, Chen LY et al. (2020) Latifolin protects against myocardial infarction by alleviating myocardial inflammatory via the HIF-1α/NF-κB/IL-6 pathway. Pharm Biol 58:1156–1166.
https://doi.org/10.1080/13880209.2020.1840597 - Liu D, Ding J, Li Z et al. (2024) Pachymic acid (PA) inhibits ferroptosis of cardiomyocytes via activation of the AMPK in mice with ischemia/reperfusion-induced myocardial injury. Cell Biol Int 48:46–59.
https://doi.org/10.1002/cbin.12090 - Li H, Yang DH, Zhang Y et al. (2022) Geniposide suppresses NLRP3 inflammasome-mediated pyroptosis via the AMPK signaling pathway to mitigate myocardial ischemia/reperfusion injury. Chin Med 17:73.
https://doi.org/10.1186/s13020-022-00616-5 - Lu H, Xiao H, Dai M et al. (2022) Britanin relieves ferroptosis-mediated myocardial ischaemia/reperfusion damage by upregulating GPX4 through activation of AMPK/GSK3β/Nrf2 signalling. Pharm Biol 60:38–45.
https://doi.org/10.1080/13880209.2021.2007269 - Salari N, Morddarvanjoghi F, Abdolmaleki A et al. (2023) The global prevalence of myocardial infarction: A systematic review and meta-analysis. BMC Cardiovasc Disord 23:206.
https://doi.org/10.1186/s12872-023-03231-w - Shan T, Li X, Xie W et al. (2024b) Rap1GAP exacerbates myocardial infarction by regulating the AMPK/SIRT1/NF-κB signaling pathway. Cell Signal 117:111080.
https://doi.org/10.1016/j.cellsig.2024.111080 - Shan X, Li J, Hong B et al. (2024a) Comparative efficacy of sweated and non-sweated Salvia miltiorrhiza Bge. extracts on acute myocardial ischemia via regulating the PPARα/RXRα/NF-κB signaling pathway. Heliyon 10:e31923.
https://doi.org/10.1016/j.heliyon.2024.e31923 - Shen H, Pei H, Zhai L et al. (2022a) Salvianolic acid C improves cerebral ischemia reperfusion injury through suppressing microglial cell M1polarization and promoting cerebral angiogenesis. Int Immunopharmacol 110:109021.
https://doi.org/10.1016/j.intimp.2022.109021 - Shen Y, Shen X, Wang S et al. (2022b) Protective effects of Salvianolic acid B on rat ferroptosis in myocardial infarction through upregulating the Nrf2 signaling pathway. Int Immunopharmacol 112:109257.
https://doi.org/10.1016/j.intimp.2022.109257 - Tan YF, Fu YH, Zhang MZ (2023) Shexiang tongxin dropping pill allieviates heart failure via extracellula matrix-receptor interaction pathways based on RNA-seq transcriptomics and experimental studies. Chin J Integr Med 29:600–607.
https://doi.org/10.1007/s11655-023-3633-0 - Wang H, Hua J, Chen S et al. (2022) SERPINB1 overexpression protects myocardial damage induced by acute myocardial infarction through AMPK/mTOR pathway. BMC Cardiovasc Disord 22:107.
https://doi.org/10.1186/s12872-022-02454-7 - Wu CT, Deng JS, Huang WC et al. (2019) Salvianolic acid C against acetaminophen-induced acute liver injury by attenuating inflammation, oxidative stress, and apoptosis through inhibition of the keap1/Nrf2/HO-1 signaling. Oxid Med Cell Longev 2019:9056845.
https://doi.org/10.1155/2019/9056845 - Wu M, Lin J, Huang D et al. (2023a) Salvianolic acid C inhibits the epithelial-mesenchymal transition and ameliorates renal tubulointerstitial fibrosis. Front Biosci 28:121.
https://doi.org/10.31083/j.fbl2806121 - Wu YT, Zhang GY, Hua Y et al. (2023b) Ferrostatin-1 suppresses cardiomyocyte ferroptosis after myocardial infarction by activating Nrf2 signaling. J Pharm Pharmacol 75:1467–1477.
https://doi.org/10.1093/jpp/rgad080 - Wu YT, Zhang GY, Li L et al. (2024) Salvia miltiorrhiza suppresses cardiomyocyte ferroptosis after myocardial infarction by activating Nrf2 signaling. J Ethnopharmacol 330:118214.
https://doi.org/10.1016/j.jep.2024.118214 - Xing Y, Huang D, Lin P et al. (2025) Salvianolic acid C promotes renal gluconeogenesis in fibrotic kidneys through PGC1α. Biochem Biophys Res Commun 744:151174.
https://doi.org/10.1016/j.bbrc.2024.151174 - Xu S, Xia X, Liu Y et al. (2022) Remote cyclic compression ameliorates myocardial infarction injury in rats via AMPK-dependent pathway. Microvasc Res 141:104313.
https://doi.org/10.1016/j.mvr.2022.104313 - Xu Y, Lin H, Wang H et al. (2021) Fraxetin attenuates ferroptosis in myocardial infarction via AKT/Nrf2/HO-1 signaling. Am J Transl Res 13:10315–10327.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8507044/ - Yan J, Liu H, Shang J et al. (2024) Protective effects of Shexiang-Tongxin dropping pill against acute myocardial infarction in rats through inhibition of apoptosis and ERK/MAPK signaling pathways. Heliyon 10:e39939.
https://doi.org/10.1016/j.heliyon.2024.e39939 - Yu Q, Zhang N, Gan X et al. (2023) EGCG attenuated acute myocardial infarction by inhibiting ferroptosis via miR-450b-5p/ACSL4 axis. Phytomedicine 119:154999.
https://doi.org/10.1016/j.phymed.2023.154999 - Zhang M, Zhao Z, Shen M et al. (2017) Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3. Biochim Biophys Acta Mol Basis Dis 1863:1962–1972.
https://doi.org/10.1016/j.bbadis.2016.09.003 - Zhang X, Huang D, Zhao J et al. (2025) Hypertension and burden of myocardial infarction in China: Risk factors, gender differences and temporal trends from a National Chronic Disease Surveillance study (2021–2023). Blood Press 34:2487584.
https://doi.org/10.1080/08037051.2025.2487584 - Zhu L, Yang YM, Huang Y et al. (2024) Shexiang tongxin dropping pills protect against ischemic stroke-induced cerebral microvascular dysfunction via suppressing TXNIP/NLRP3 signaling pathway. J Ethnopharmacol 322:117567.
https://doi.org/10.1016/j.jep.2023.117567
DOI: https://doi.org/10.2478/aite-2026-0015 | Journal eISSN: 1661-4917
Language: English
Submitted on: Oct 11, 2025
Accepted on: Mar 3, 2026
Published on: May 16, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Related subjects:
© 2026 Yanping Zeng, Lin Chen, Zhenhua Qian, Weixing Ma, Cheng Ma, Yan Wang, Guanfeng Zhu, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.